+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tendonitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Therapy (Therapy v/s Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others), By Region and Competition

  • PDF Icon

    Report

  • 114 Pages
  • March 2023
  • Region: Global
  • TechSci Research
  • ID: 5768451
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global Tendonitis Treatment Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing incidence of bone-related injuries among the aging population due to osteoporosis or weak bone. Additionally, the growing demand for the best treatment with a low cost, along with increasing awareness about new therapies such as joint manipulation and physical therapy, will significantly increase the demand for the tendonitis treatment market across different parts of the globe. Additionally, the growing improvement of healthcare infrastructure for the treatment of bone disorders across the globe is further expected to increase the demand for tendonitis treatment, thereby fuelling market growth through 2027. Besides growing awareness about maintaining a healthy lifestyle, people are looking for sports activities which will further be expected to support the tendonitis treatment market growth during the forecast period. Furthermore, an increased number of sport-related injuries due to either trauma or overuse of muscles or joints, improper rehabilitation, and imbalanced training sessions are further expected to increase the demand for tendonitis treatment, thereby supporting market growth. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Increased Number of Sport-Related Injuries

The rapid increase in sport-related activities causing sport-related injuries is expected to create lucrative growth during the forecast period. Sports injuries can cause soft tissue injuries, which can be a major market driver across the globe. The number of people choosing sports as their career or hobby and getting work opportunities in the field of sports has increased. Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University. Tendonitis is becoming more common day by day in the population, and 5-10 cases per 100,000 population get affected, which is expected to boost the market during the forecast period. Similarly, the number of patients are demanding physical therapy and minimally invasive surgeries, which will propel the market growth during the forecast period.

Stryker has launched the Citrelock Tendon Fixation Device system at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting, which was held from 22-25 September 2021 in Charlotte, North Carolina, US, and designed to enable fixation without causing damage to the tendon during placement.

Growing Aging Population

Different types of chronic disorders are affecting people across the globe. In Tendonitis, a thick fibrous cord that connects muscle and bone becomes infected. The growing cases of Tendonitis, majorly among the aging population, are expected to enhance the demand for tendonitis treatment and boost the market growth during the forecast period. There are an estimated 32.0 million tendon injuries reported each year on average across the globe. So, most of the patients who are injured due to accidents demand physical therapy, over-the-counter pain relievers, and surgical procedures, which will further propel the market growth during the forecast period. Eccentric strengthening is the main treatment for tendon disorders, so physical therapy is the first line of treatment for tendonitis, which will boost the market growth during the forecast period. These are the major factor in the growth of the global Tendonitis Treatment Market in the forecast period. Every year in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year due to sports injuries will enhance the demand for tendonitis treatment. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Market Segmentation

The global tendonitis treatment market can be segmented by therapy, condition, and by region. Based on therapy, the market can be divided into Therapy and Surgery. Based on the condition, the market can be differentiated into Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global tendonitis treatment market on account of the growing demand for advanced technology for the better treatment of tendonitis injuries in the country. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S.

Market Players

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.

Recent Development

  • Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).

Report Scope:

In this report, the global tendonitis treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Tendonitis Treatment Market, By Therapy:

  • Therapy
  • Surgery

Tendonitis Treatment Market, By Condition:

  • Tennis Elbow
  • Golfer’s Elbow
  • Pitcher’s Elbow
  • Jumper’s Knee
  • Others

Tendonitis Treatment Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tendonitis Treatment Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
4.1. Prevalence of Tendonitis, By Age Group
4.2. Prevalence of Tendonitis, By Gender
4.3. Prevalence of Tendonitis, By Region
4.4. Commonly Observed Tendonitis Conditions
5. Global Tendonitis Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Therapy v/s Surgery)
5.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
5.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Condition
5.3.3. By Region
6. North America Tendonitis Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Therapy v/s Surgery)
6.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
6.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Tendonitis Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Condition
6.3.2. Canada Tendonitis Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Condition
6.3.3. Mexico Tendonitis Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Condition
7. Europe Tendonitis Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Therapy v/s Surgery)
7.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
7.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Tendonitis Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Condition
7.3.2. Germany Tendonitis Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Condition
7.3.3. United Kingdom Tendonitis Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Condition
7.3.4. Italy Tendonitis Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Condition
7.3.5. Spain Tendonitis Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Condition
8. Asia-Pacific Tendonitis Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Therapy v/s Surgery)
8.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
8.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Tendonitis Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Condition
8.3.2. India Tendonitis Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Condition
8.3.3. Japan Tendonitis Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Condition
8.3.4. South Korea Tendonitis Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Condition
8.3.5. Australia Tendonitis Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Condition
9. South America Tendonitis Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Therapy v/s Surgery)
9.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
9.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Tendonitis Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Condition
9.3.2. Argentina Tendonitis Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Condition
9.3.3. Colombia Tendonitis Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Condition
10. Middle East and Africa Tendonitis Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Therapy v/s Surgery)
10.2.1.1.By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
10.2.2. By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Tendonitis Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Condition
10.3.2. Saudi Arabia Tendonitis Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Condition
10.3.3. UAE Tendonitis Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Condition
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments13. Global Tendonitis Treatment Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Merck and Co. Inc.
15.6.2 Bayer AG
15.6.3 AstraZeneca Plc.
15.6.4 Boehringer Ingelheim Pharmaceuticals, Inc.
15.6.5 Abbott Laboratories, Inc.
15.6.6 Pfizer, Inc.
15.6.7 GlaxoSmithKline PLC
15.6.8 Almatica Pharma, Inc.
16. Strategic Recommendations

Companies Mentioned

  • Merck and Co. Inc.
  • Bayer AG
  • AstraZeneca Plc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.